Induction of Therapeutic Antitumor Immunity by In Vivo Administration of a Lentiviral Vaccine
Authors:
- 1 November 2005
- journal article
- Published by SAGE Publications in Human Gene Therapy
- Vol. 16 (11) , 1255-1266
Abstract
Direct in vivo administration of a lentiviral vaccine has been shown to transduce dendritic cells (DCs) in order to induce antigen-specific CD8+ T cell responses, but the efficacy of antitumor immunity has not been reported. In this study we tested whether direct in vivo administration of a lentiviral vaccine can induce selfantigen- based therapeutic antitumor immunity in murine tumor models. Lentiviral vector (LV) transduced DCs efficiently in vitro and was able to transduce DCs in vivo. LV-transduced DCs effectively presented antigens to T cells. Compared with a naked DNA tyrosinase-related protein-2 (TRP2)-heat shock protein-70 (hsp70) vaccine, the TRP2-specific interferon-gamma-producing CD8+ T cell response was augmented by direct in vivo administration of an LV-TRP2hsp70 vaccine, which induced significant therapeutic antitumor immunity in subcutaneous B16 and subcutaneous GL-26 models. Moreover, in vivo administration of an LV-NeuEDhsp70 vaccine induced significant therapeutic antitumor immunity against spontaneous breast tumors in a BALB/c- Neu transgenic model. Our observations indicate that direct in vivo administration of a lentiviral vaccine not only enhances antigen-specific CD8+ T cell responses, but also generates significant therapeutic antitumor activities.Keywords
This publication has 37 references indexed in Scilit:
- Enhanced immunity by NeuEDhsp70 DNA vaccine Is needed to combat an aggressive spontaneous metastatic breast cancerMolecular Therapy, 2005
- Characterization of Dendritic Cells that Induce Tolerance and T Regulatory 1 Cell Differentiation In VivoImmunity, 2003
- A Serious Adverse Event after Successful Gene Therapy for X-Linked Severe Combined ImmunodeficiencyNew England Journal of Medicine, 2003
- Lentiviral vectors containing the human immunodeficiency virus type-1 central polypurine tract can efficiently transduce nondividing hepatocytes and antigen-presenting cells in vivoBlood, 2002
- Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cellsNature Biotechnology, 2002
- Use of a lentiviral flap vector for induction of CTL immunity against melanoma. Perspectives for immunotherapyThe Journal of Gene Medicine, 2002
- DNA Vaccines: Immunology, Application, and OptimizationAnnual Review of Immunology, 2000
- Identification of Tyrosinase-related Protein 2 as a Tumor Rejection Antigen for the B16 MelanomaJournal of Experimental Medicine, 1997
- Human tumor antigens recognized by T lymphocytes.Journal of Experimental Medicine, 1996
- The neu oncogene encodes an epidermal growth factor receptor-related proteinNature, 1986